Tuesday, September 25, 2018

Genetic testing: Not a one-and-done deal

A study that reviewed genetic testing results from 1.45 million individuals found that nearly 25 percent of 'variants of uncertain significance' were subsequently reclassified -- sometimes as less likely to be associated with cancer, sometimes as more likely.

from Top Health News -- ScienceDaily https://ift.tt/2Q4MNV2

No comments:

Post a Comment

Ozempic may have revealed the brain’s hidden “craving center”

Ozempic-like drugs appear to weaken more than hunger—they may also reduce cravings for alcohol and other addictive substances. Scientists ar...